$4.47 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 122 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 27.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Buy | GLAUKOS CORPnote 2.750% 6/1 | $358,786,000 | +48.0% | 269,897,000 | +31.9% | 8.02% | +57.7% | |
NUVALENT INC | $268,647,000 | -27.0% | 19,341,024 | 0.0% | 6.01% | -22.2% | ||
VTRS | Sell | VIATRIS INC | $224,930,000 | -20.0% | 20,673,700 | -0.5% | 5.03% | -14.7% |
AHCO | Buy | ADAPTHEALTH CORP | $186,751,000 | -25.3% | 11,650,072 | +13.9% | 4.18% | -20.4% |
Buy | INVITAE CORPnote 2.000% 9/0 | $169,769,000 | +10.7% | 206,873,000 | +26.6% | 3.80% | +18.0% | |
NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $155,419,000 | +32.4% | 1,657,800 | +20.3% | 3.48% | +41.1% |
AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $141,877,000 | +9.0% | 157,390,000 | 0.0% | 3.17% | +16.2% | ||
ENVISTA HOLDINGS CORPORATIONnote 2.375% 6/0 | $123,924,000 | +6.3% | 52,500,000 | 0.0% | 2.77% | +13.3% | ||
CMAX | Sell | CAREMAX INC | $121,813,000 | -5.5% | 15,861,090 | -5.5% | 2.72% | +0.7% |
Buy | NATERA INCnote 2.250% 5/0 | $120,177,000 | +3.8% | 90,638,000 | +101.4% | 2.69% | +10.7% | |
New | SAREPTA THERAPEUTICS INCdbcv 1.500%11/1 | $116,124,000 | – | 88,657,000 | +100.0% | 2.60% | – | |
PACIRA BIOSCIENCES INCnote 0.750% 8/0 | $100,908,000 | +11.5% | 81,600,000 | 0.0% | 2.26% | +18.9% | ||
NUVASIVE INCnote 1.000% 6/0 | $96,433,000 | -0.2% | 96,966,000 | 0.0% | 2.16% | +6.4% | ||
LUNG | Buy | PULMONX CORP | $91,681,000 | +20.8% | 3,695,341 | +56.1% | 2.05% | +28.8% |
SILK | Buy | SILK RD MED INC | $88,927,000 | +37.6% | 2,153,712 | +42.0% | 1.99% | +46.6% |
ISEE | Buy | IVERIC BIO INC | $82,332,000 | +3.4% | 4,891,996 | +2.7% | 1.84% | +10.2% |
Buy | APELLIS PHARMACEUTICALS INCnote 3.500% 9/1 | $81,724,000 | +87.7% | 51,885,000 | +80.0% | 1.83% | +100.1% | |
Buy | TABULA RASA HEALTHCARE INCnote 1.750% 2/1 | $79,740,000 | -0.9% | 107,816,000 | +10.2% | 1.78% | +5.6% | |
INSULET CORPnote 0.375% 9/0 | $76,232,000 | -0.2% | 57,581,000 | 0.0% | 1.70% | +6.4% | ||
Buy | NUVASIVE INCnote 0.375% 3/1 | $76,133,000 | +1.9% | 80,000,000 | +2.7% | 1.70% | +8.6% | |
Buy | INSMED INCnote 1.750% 1/1 | $74,929,000 | +46.0% | 75,000,000 | +50.0% | 1.68% | +55.7% | |
MIRM | MIRUM PHARMACEUTICALS INC | $72,290,000 | +38.1% | 3,282,912 | 0.0% | 1.62% | +47.2% | |
KURA | Buy | KURA ONCOLOGY INC | $71,015,000 | +44.4% | 4,416,361 | +25.7% | 1.59% | +53.9% |
NEVRO CORPnote 2.750% 4/0 | $65,368,000 | -4.1% | 61,000,000 | 0.0% | 1.46% | +2.2% | ||
ORGO | ORGANOGENESIS HLDGS INC | $64,441,000 | -17.5% | 8,456,876 | 0.0% | 1.44% | -12.1% | |
INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $52,992,000 | -2.6% | 57,791,000 | 0.0% | 1.18% | +3.9% | ||
DCPH | DECIPHERA PHARMACEUTICALS IN | $51,731,000 | -5.1% | 5,580,456 | 0.0% | 1.16% | +1.1% | |
HZNP | New | HORIZON THERAPEUTICS PUB L | $48,923,000 | – | 465,000 | +100.0% | 1.09% | – |
BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $47,402,000 | -19.5% | 80,000,000 | 0.0% | 1.06% | -14.2% | ||
CNC | Sell | CENTENE CORP DEL | $46,624,000 | -43.6% | 553,800 | -44.8% | 1.04% | -39.9% |
GILD | New | GILEAD SCIENCES INC | $45,508,000 | – | 765,489 | +100.0% | 1.02% | – |
MOH | MOLINA HEALTHCARE INC | $45,031,000 | +4.9% | 134,989 | 0.0% | 1.01% | +11.8% | |
AERI | AERIE PHARMACEUTICALS INC | $42,725,000 | +29.6% | 4,695,020 | 0.0% | 0.96% | +38.2% | |
Sell | SEMA4 HOLDINGS CORP | $42,515,000 | -31.7% | 13,848,488 | -0.8% | 0.95% | -27.3% | |
OMIC | Sell | SINGULAR GENOMICS SYSTEMS IN | $41,722,000 | -60.4% | 6,612,019 | -27.4% | 0.93% | -57.8% |
ATEC | ALPHATEC HLDGS INC | $41,341,000 | +0.6% | 3,594,829 | 0.0% | 0.92% | +7.2% | |
EWTX | EDGEWISE THERAPEUTICS INC | $38,151,000 | -36.5% | 3,933,137 | 0.0% | 0.85% | -32.4% | |
BKD | Buy | BROOKDALE SR LIVING INC | $37,922,000 | +71.9% | 5,379,000 | +25.8% | 0.85% | +83.2% |
CYTK | Buy | CYTOKINETICS INC | $35,069,000 | -4.9% | 952,703 | +17.8% | 0.78% | +1.4% |
New | 1LIFE HEALTHCARE INCnote 3.000% 6/1 | $34,716,000 | – | 40,000,000 | +100.0% | 0.78% | – | |
THE ONCOLOGY INSTITUTE INC | $32,137,000 | 0.0% | 3,296,107 | 0.0% | 0.72% | +6.5% | ||
PHVS | Sell | PHARVARIS N V | $28,600,000 | +25.7% | 1,577,078 | -0.3% | 0.64% | +34.0% |
NOVAVAX INCnote 3.750% 2/0 | $26,777,000 | -22.2% | 25,000,000 | 0.0% | 0.60% | -17.0% | ||
BLU | Buy | BELLUS HEALTH INC NEW | $25,269,000 | +28.2% | 3,672,808 | +50.0% | 0.56% | +36.5% |
LRMR | LARIMAR THERAPEUTICS INC | $23,613,000 | -62.5% | 5,830,249 | 0.0% | 0.53% | -60.0% | |
RVMD | REVOLUTION MEDICINES INC | $22,744,000 | +1.4% | 891,587 | 0.0% | 0.51% | +7.9% | |
MRTX | Buy | MIRATI THERAPEUTICS INC | $22,199,000 | +72.0% | 270,000 | +206.8% | 0.50% | +83.0% |
GKOS | Sell | GLAUKOS CORP | $21,365,000 | -58.6% | 369,514 | -68.2% | 0.48% | -55.9% |
XERIS BIOPHARMA HOLDINGS INCnote 5.000% 7/1 | $21,095,000 | -2.2% | 18,000,000 | 0.0% | 0.47% | +4.2% | ||
DAWN | Sell | DAY ONE BIOPHARMACEUTICALS I | $20,698,000 | -44.2% | 2,086,449 | -5.3% | 0.46% | -40.5% |
GDRX | New | GOODRX HLDGS INC | $18,926,000 | – | 979,106 | +100.0% | 0.42% | – |
NUVB | NUVATION BIO INC | $18,816,000 | -38.1% | 3,577,233 | 0.0% | 0.42% | -34.0% | |
OM | OUTSET MED INC | $18,188,000 | -1.5% | 400,622 | 0.0% | 0.41% | +5.2% | |
HEALTH CATALYST INCnote 2.500% 4/1 | $17,171,000 | -21.2% | 15,000,000 | 0.0% | 0.38% | -16.0% | ||
IMGN | New | IMMUNOGEN INC | $16,520,000 | – | 3,470,675 | +100.0% | 0.37% | – |
BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $16,455,000 | -29.5% | 1,012,000 | -40.0% | 0.37% | -24.9% |
DA32 LIFE SCNCE TEC ACQSTN C | $15,544,000 | -1.0% | 1,600,000 | 0.0% | 0.35% | +5.8% | ||
PROF | PROFOUND MED CORP | $15,424,000 | -19.9% | 1,713,797 | 0.0% | 0.34% | -14.6% | |
PTC THERAPEUTICS INCnote 3.000% 8/1 | $15,076,000 | -1.6% | 14,527,000 | 0.0% | 0.34% | +5.0% | ||
ALEC | ALECTOR INC | $15,036,000 | -31.0% | 1,055,192 | 0.0% | 0.34% | -26.5% | |
Sell | XILIO THERAPEUTICS INC | $14,696,000 | -56.4% | 2,078,692 | -3.5% | 0.33% | -53.5% | |
New | OAK STR HEALTH INCnote 3/1 | $14,316,000 | – | 18,000,000 | +100.0% | 0.32% | – | |
SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $14,109,000 | -49.6% | 249,988 | -44.7% | 0.32% | -46.4% |
EOLS | New | EVOLUS INC | $13,792,000 | – | 1,229,234 | +100.0% | 0.31% | – |
KALV | Sell | KALVISTA PHARMACEUTICALS INC | $12,241,000 | -21.3% | 830,472 | -29.3% | 0.27% | -16.0% |
COGT | COGENT BIOSCIENCES INC | $11,991,000 | -12.7% | 1,601,000 | 0.0% | 0.27% | -6.9% | |
MRUS | MERUS N V | $11,554,000 | -16.9% | 437,000 | 0.0% | 0.26% | -11.3% | |
KNTE | KINNATE BIOPHARMA INC | $11,097,000 | -36.5% | 985,568 | 0.0% | 0.25% | -32.2% | |
APEN | APOLLO ENDOSURGERY INC | $10,588,000 | -28.2% | 1,750,000 | 0.0% | 0.24% | -23.3% | |
SRSA | SARISSA CAPITAL ACQUISITN COcl a | $9,900,000 | +1.1% | 999,999 | 0.0% | 0.22% | +7.8% | |
EUCR | EUCRATES BIOMEDICAL ACQU COR | $9,840,000 | +0.8% | 999,999 | 0.0% | 0.22% | +7.3% | |
SNRH | SENIOR CONNECT ACQUISITN COR | $9,820,000 | +0.8% | 1,000,000 | 0.0% | 0.22% | +7.8% | |
REVH | REVOLUTION HEALTHCAR AQ CORP | $9,810,000 | +0.7% | 1,000,000 | 0.0% | 0.22% | +7.4% | |
MTAC | MEDTECH ACQUISITION CORP | $9,800,000 | -0.8% | 999,999 | 0.0% | 0.22% | +5.8% | |
INZY | INOZYME PHARMA INC | $9,590,000 | -40.0% | 2,344,786 | 0.0% | 0.21% | -36.1% | |
New | AN2 THERAPEUTICS INC | $8,803,000 | – | 584,136 | +100.0% | 0.20% | – | |
NYXOAH S A | $8,714,000 | -16.8% | 455,262 | 0.0% | 0.20% | -11.4% | ||
TMPM | TURMERIC ACQUISITION CORPcl a | $7,388,000 | +0.3% | 750,000 | 0.0% | 0.16% | +7.1% | |
INSM | New | INSMED INC | $7,157,000 | – | 304,572 | +100.0% | 0.16% | – |
IGNY | IGNYTE ACQUISITION CORP | $7,134,000 | +1.0% | 725,000 | 0.0% | 0.16% | +7.4% | |
TERN | TERNS PHARMACEUTICALS INC | $6,967,000 | -58.0% | 2,345,959 | 0.0% | 0.16% | -55.2% | |
QSI | QUANTUM SI INC | $6,552,000 | -40.5% | 1,400,000 | 0.0% | 0.15% | -36.8% | |
GRAY | GRAYBUG VISION INC | $6,497,000 | -32.8% | 5,281,713 | 0.0% | 0.14% | -28.6% | |
BENEFITFOCUS INCnote 1.250%12/1 | $6,311,000 | +1.3% | 6,500,000 | 0.0% | 0.14% | +7.6% | ||
ONCR | ONCORUS INC | $5,605,000 | -66.2% | 3,148,977 | 0.0% | 0.12% | -64.1% | |
VINC | VINCERX PHARMA INC | $5,517,000 | -60.7% | 1,379,310 | 0.0% | 0.12% | -58.3% | |
ORTX | ORCHARD THERAPEUTICS PLCads | $4,948,000 | -46.1% | 6,949,416 | 0.0% | 0.11% | -42.2% | |
OHPA | ORION ACQUISITION CORP | $4,885,000 | -0.1% | 500,000 | 0.0% | 0.11% | +5.8% | |
HOWL | WEREWOLF THERAPEUTICS INC | $4,216,000 | -63.1% | 958,125 | 0.0% | 0.09% | -60.7% | |
CGEM | Sell | CULLINAN ONCOLOGY INC | $3,932,000 | -62.1% | 375,585 | -44.1% | 0.09% | -59.4% |
AFIB | ACUTUS MED INC | $3,681,000 | -59.2% | 2,648,386 | 0.0% | 0.08% | -56.6% | |
FHTX | New | FOGHORN THERAPEUTICS INC | $3,638,000 | – | 238,865 | +100.0% | 0.08% | – |
RYTM | Sell | RHYTHM PHARMACEUTICALS INC | $3,352,000 | -82.0% | 291,005 | -84.4% | 0.08% | -80.8% |
DCTH | DELCATH SYS INC | $3,200,000 | -17.4% | 500,000 | 0.0% | 0.07% | -11.1% | |
GKOS | GLAUKOS CORPcall | $2,613,000 | +30.1% | 45,200 | 0.0% | 0.06% | +38.1% | |
AMWL | Sell | AMERICAN WELL CORPcl a | $1,647,000 | -72.5% | 391,115 | -60.5% | 0.04% | -70.6% |
NEOGENOMICS INCnote 0.250% 1/1 | $1,666,000 | -21.9% | 2,500,000 | 0.0% | 0.04% | -17.8% | ||
ANNX | ANNEXON INC | $1,594,000 | -76.2% | 583,913 | 0.0% | 0.04% | -74.5% | |
THE ONCOLOGY INSTITUTE INC*w exp 11/15/202 | $1,438,000 | +66.6% | 1,250,000 | 0.0% | 0.03% | +77.8% | ||
BCAB | BIOATLA INC | $1,445,000 | -74.5% | 289,002 | 0.0% | 0.03% | -73.1% | |
CMAXW | CAREMAX INC*w exp 06/08/202 | $1,277,000 | +35.7% | 672,000 | 0.0% | 0.03% | +45.0% | |
MDVL | MEDAVAIL HOLDINGS INC | $1,110,000 | -30.6% | 1,142,552 | 0.0% | 0.02% | -26.5% | |
CABA | CABALETTA BIO INC | $942,000 | -46.5% | 464,252 | 0.0% | 0.02% | -43.2% | |
ROIVANT SCIENCES LTD*w exp 09/30/202 | $880,000 | -57.0% | 1,000,000 | 0.0% | 0.02% | -53.5% | ||
BFLYWS | BUTTERFLY NETWORK INC*w exp 02/12/202 | $748,000 | -19.7% | 733,333 | 0.0% | 0.02% | -15.0% | |
QSIAW | QUANTUM SI INC*w exp 06/10/202 | $383,000 | -36.2% | 333,333 | 0.0% | 0.01% | -30.8% | |
SOMALOGIC INC*w exp 08/31/202 | $257,000 | -35.9% | 120,000 | 0.0% | 0.01% | -25.0% | ||
SRSAW | New | SARISSA CAPITAL ACQUISITN CO*w exp 10/23/202 | $120,000 | – | 333,333 | +100.0% | 0.00% | – |
NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $135,000 | -57.1% | 166,666 | 0.0% | 0.00% | -57.1% | |
IGNYW | IGNYTE ACQUISITION CORP*w exp 01/05/202 | $132,000 | -52.7% | 362,500 | 0.0% | 0.00% | -50.0% | |
TMPMW | TURMERIC ACQUISITION CORP*w exp 10/08/202 | $82,000 | -51.8% | 250,000 | 0.0% | 0.00% | -50.0% | |
REVHW | REVOLUTION HEALTHCAR AQ CORP*w exp 12/31/202 | $90,000 | -40.0% | 200,000 | 0.0% | 0.00% | -33.3% | |
MTACW | MEDTECH ACQUISITION CORP*w exp 12/22/202 | $85,000 | -51.1% | 333,333 | 0.0% | 0.00% | -50.0% | |
SNRHW | SENIOR CONNECT ACQUISITN COR*w exp 12/31/202 | $90,000 | -65.8% | 500,000 | 0.0% | 0.00% | -66.7% | |
OHPAW | ORION ACQUISITION CORP*w exp 02/19/202 | $39,000 | -51.9% | 125,000 | 0.0% | 0.00% | -50.0% | |
EUCRW | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $62,000 | -67.9% | 333,333 | 0.0% | 0.00% | -75.0% | |
SURROZEN INC*w exp 08/01/203 | $42,000 | -78.1% | 166,666 | 0.0% | 0.00% | -75.0% | ||
WINT | WINDTREE THERAPEUTICS INC | $23,000 | -28.1% | 20,148 | 0.0% | 0.00% | 0.0% | |
SRSAU | New | SARISSA CAPITAL ACQUISITN COunit 10/23/2027 | $0 | – | 1 | +100.0% | 0.00% | – |
MTACU | New | MEDTECH ACQUISITION CORPunit 12/18/2025 | $0 | – | 1 | +100.0% | 0.00% | – |
PMVP | Sell | PMV PHARMACEUTICALS INC | $10,000 | -99.9% | 470 | -99.9% | 0.00% | -100.0% |
EUCRU | New | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $0 | – | 1 | +100.0% | 0.00% | – |
BDSI | Exit | BIODELIVERY SCIENCES INTL IN | $0 | – | -29,204 | -100.0% | -0.00% | – |
WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -552,690 | -100.0% | -0.04% | – |
Exit | PYXIS ONCOLOGY INC | $0 | – | -311,754 | -100.0% | -0.07% | – | |
Exit | DEFINITIVE HEALTHCARE CORP | $0 | – | -250,000 | -100.0% | -0.14% | – | |
Exit | HYPERFINE INC | $0 | – | -1,000,000 | -100.0% | -0.15% | – | |
PRVA | Exit | PRIVIA HEALTH GROUP INC | $0 | – | -300,000 | -100.0% | -0.16% | – |
Exit | GUARDANT HEALTH INCnote 11/1 | $0 | – | -8,000,000 | -100.0% | -0.17% | – | |
Exit | WEAVE COMMUNICATIONS INC | $0 | – | -554,519 | -100.0% | -0.18% | – | |
Exit | LIANBIOsponsored ads | $0 | – | -1,782,747 | -100.0% | -0.23% | – | |
BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -110,000 | -100.0% | -0.25% | – |
SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -141,000 | -100.0% | -0.27% | – |
APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -343,213 | -100.0% | -0.34% | – |
BBIO | Exit | BRIDGEBIO PHARMA INCcall | $0 | – | -1,000,000 | -100.0% | -0.35% | – |
NVRO | Exit | NEVRO CORP | $0 | – | -216,000 | -100.0% | -0.37% | – |
FIGS | Exit | FIGS INCcl a | $0 | – | -829,707 | -100.0% | -0.48% | – |
VIVO | Exit | MERIDIAN BIOSCIENCE INC | $0 | – | -1,125,083 | -100.0% | -0.48% | – |
ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -5,000,000 | -100.0% | -0.52% | – |
PCRX | Exit | PACIRA BIOSCIENCES INC | $0 | – | -596,338 | -100.0% | -0.75% | – |
PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -1,172,943 | -100.0% | -0.84% | – |
APR | Exit | APRIA INC | $0 | – | -1,655,795 | -100.0% | -1.13% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
EHEALTH INC | 25 | Q3 2020 | 2.0% |
INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
MYLAN NV | 23 | Q3 2020 | 6.2% |
PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
3 | 2024-03-19 |
4 | 2024-03-19 |
4 | 2024-03-12 |
3 | 2024-03-08 |
4 | 2024-02-16 |
13F-HR | 2024-02-14 |
4 | 2024-02-08 |
3 | 2024-02-01 |
4 | 2023-11-21 |
13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.